Clinical Trial Update: Platelet Reactivity Inhibition Following Ticagrelor Loading Dose and One Year Outcome [NA]

View source ↗

Summary

A completed clinical trial update evaluating platelet reactivity after a ticagrelor loading dose and tracking outcomes over one year in acute coronary syndrome …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• BRILINTA (ticagrelor)

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Acute Coronary Syndrome | NA | Status: COMPLETED